Nama Insights

Johnson & Johnson (JNJ)

Healthcare · Drug Manufacturers General · NYSE

S&P 500
Johnson & Johnson (JNJ) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $624.74B, a trailing price-to-earnings ratio of 23.9 and a free-cash-flow yield of 3.1%. Over the most recent reported fiscal year, revenue grew 6.0% and free cash flow per share grew 6.9%.
Market cap$624.74B
Trailing P/E23.9
FCF yield3.1%
Revenue growth (YoY)+6.0%
EPS growth (YoY)+8.1%
FCF/share growth (YoY)+6.9%
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers General
Explore live JNJ data on Nama Insights →

Recent Congressional trades

Johnson & Johnson trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Lloyd Doggett House Buy $1,001 - $15,000 Jul 6, 2026
Lloyd Doggett House Buy $1,001 - $15,000 Jan 2, 2026
Lisa McClain House Sell $1,001 - $15,000 Nov 1, 2025
Lisa McClain House Sell $1,001 - $15,000 Nov 1, 2025
Valerie Hoyle House Sell $1,001 - $15,000 Sep 23, 2025
Valerie Hoyle House Buy $1,001 - $15,000 Sep 11, 2025
Lisa McClain House Buy $1,001 - $15,000 Aug 13, 2025
Lisa McClain House Sell $1,001 - $15,000 Aug 13, 2025
Sheri Biggs House Sell $15,001 - $50,000 Aug 11, 2025
Ritchie John Torres House Buy $1,001 - $15,000 Aug 1, 2025
Pete Sessions House Sell $15,001 - $50,000 Jun 21, 2025
Scott Scott Franklin House Sell $15,001 - $50,000 Jun 17, 2025